Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks


Large Scale Sequencing and Analysis

It is expected that routine clinical sequencing and the accompanying analyses are soon going beyond gene panels and will include extensive exome and whole genome sequencing. This will result in large amounts of sequence data that needs to be stored, analyzed, and made accessible for future interrogations. In order to achieve this, a scalable and powerful computational infrastructure has to be in place in addition to technologies and tools that support the evaluation of this data in the context of human diseases, both in a research and clinical setting.


David Glazer, Engineering Director, Google

David is an engineering director at Google, currently helping life science organizations use Google's Cloud Platform to accelerate and scale their work with big data. His previous projects at Google include creating and leading the Google+ Platform team. Read Full Bio

Jurgi Camblong, Ph.D., CEO & Co-founder, Sophia Genetics

Jurgi Camblong is a young entrepreneur whose training was in biochemistry and molecular biology. He holds a PhD in Life Sciences (University of Geneva) and an EMBA in Management of Technology (EPFL-HEC Lausanne). Read Full Bio

Sebastian Wernicke, Ph.D., Managing Director, Seven Bridges Genomics

Sebastian Wernicke leads the strategy and growth of Seven Bridges Genomics, a Cambridge-based company that builds and deploys platforms for Next Generation Sequencing analysis. He also serves as director of Seven Bridges Genomics UK. Read Full Bio

Web Analytics